Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
CAMBRIDGE, United Kingdom & CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)– Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody®-based therapeutics, and Takeda Pharmaceutical...